CD9:PA:PA-Amundi MSCI Europe High Dividend UCITS (EUR)

ETF | Others |

Last Closing

USD 172.46

Change

-1.12 (-0.65)%

Market Cap

USD 0.11B

Volume

813.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-02 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

+0.03 (+0.06%)

USD 66.12B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

+3.00 (+0.60%)

USD 10.74B
WRD:PA HSBC ETFs Public Limited Compa..

+0.09 (+0.28%)

USD 9.02B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

-2.45 (-1.02%)

USD 7.57B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

+3.50 (+0.79%)

USD 6.92B
HHH:PA HSBC ETFs Public Limited Compa..

+0.30 (+0.59%)

USD 6.65B
WLD:PA Lyxor UCITS MSCI World D-EUR

+0.93 (+0.29%)

USD 6.26B
LCWD:PA Multi Units Luxembourg - Lyxor..

+0.05 (+0.30%)

USD 5.24B
500U:PA Amundi Index Solutions - Amund..

+0.02 (+0.02%)

USD 4.58B
S500:PA Amundi S&P 500 ESG UCITS ETF A..

+1.07 (+0.74%)

USD 3.86B

ETFs Containing CD9:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 3.65% 43% F 54% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 3.65% 41% F 53% F
Trailing 12 Months  
Capital Gain 11.60% 51% F 65% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 11.60% 48% F 62% D
Trailing 5 Years  
Capital Gain 40.28% 56% F 67% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 40.28% 55% F 64% D
Average Annual (5 Year Horizon)  
Capital Gain 7.80% 63% D 62% D
Dividend Return 7.80% 59% D- 61% D-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 11.91% 58% F 75% C
Risk Adjusted Return 65.52% 84% B 88% B+
Market Capitalization 0.11B 34% F 48% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.